Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial

BackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg...

Full description

Bibliographic Details
Main Authors: Nahid Manouchehrian, Farshid Rahimi-Bashar, Azar Pirdehghan, Fatemeh Shahmoradi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/full
_version_ 1828340484057071616
author Nahid Manouchehrian
Farshid Rahimi-Bashar
Azar Pirdehghan
Fatemeh Shahmoradi
author_facet Nahid Manouchehrian
Farshid Rahimi-Bashar
Azar Pirdehghan
Fatemeh Shahmoradi
author_sort Nahid Manouchehrian
collection DOAJ
description BackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg of intrathecal hyperbaric bupivacaine 0.5% on sensory block level after first spinal failure in cesarean section (CS).MethodsIn this double-blind, randomized clinical trial, 40 candidates of CS after first spinal failure with class I-II based on American Society of Anesthesiologists (ASA) were randomly assigned into two equal groups (n = 20). Group A and B received the spinal anesthesia with 10 mg and 12 mg of hyperbaric bupivacaine (0.5%), respectively. Maximum levels of sensory block, motor block quality, and vital signs were measured in two groups by 60 min after SPA. Incidence of SPA complications during surgery were also recorded. Data were analyzed by SPSS ver.21 software using repeated measures analysis of variance at 95% confidence interval (CI) level.ResultsExcellent quality of sensory blocks and complete quality of motor blocks were achieved in all participants (100%). However, the mean time to onset of anesthesia (4.47 ± 0.69 vs. 3.38 ± 0.47, P < 0.001) and time to reach T10 level (60.73 ± 11.92 vs. 79.00 ± 19.21, P < 0.001) in the Group A, were significantly shorter than in the patients of Group B. The incidence of hypotension (P = 0.001), nausea/vomiting (P = 0.007) and bradycardia (P = 0.012) as well as administration of ephedrine and atropine were significantly higher in Group B compared to Group A.ConclusionSpinal anesthesia can be safely repeated with a 10 mg of hyperbaric bupivacaine 0.5% in a caesarean section after the initial spinal failure.Clinical trial registration[https://en.irct.ir/trial/40714], identifier [IRCT20120915010841N20].
first_indexed 2024-04-13T22:57:11Z
format Article
id doaj.art-e7d30e24a0d746fa93abd2934204ac02
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-13T22:57:11Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-e7d30e24a0d746fa93abd2934204ac022022-12-22T02:25:58ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-10-01910.3389/fmed.2022.937963937963Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trialNahid Manouchehrian0Farshid Rahimi-Bashar1Azar Pirdehghan2Fatemeh Shahmoradi3Department of Anesthesiology, Fatemi Medical Center, Hamadan University of Medical Sciences, Hamadan, IranAnesthesia and Critical Care Department, Hamadan University of Medical Sciences, Hamadan, IranSchool of Public Health and Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, IranFaculty of Medical Sciences, Hamadan University of Medical Sciences, Hamedan, IranBackgroundReducing adverse effects during cesarean delivery and improving the quality of sensory blocks with appropriate doses of intrathecal hyperbaric bupivacaine can play an important role in the safe management of cesarean delivery. The aim of this study was to compare the doses of 10 and 12 mg of intrathecal hyperbaric bupivacaine 0.5% on sensory block level after first spinal failure in cesarean section (CS).MethodsIn this double-blind, randomized clinical trial, 40 candidates of CS after first spinal failure with class I-II based on American Society of Anesthesiologists (ASA) were randomly assigned into two equal groups (n = 20). Group A and B received the spinal anesthesia with 10 mg and 12 mg of hyperbaric bupivacaine (0.5%), respectively. Maximum levels of sensory block, motor block quality, and vital signs were measured in two groups by 60 min after SPA. Incidence of SPA complications during surgery were also recorded. Data were analyzed by SPSS ver.21 software using repeated measures analysis of variance at 95% confidence interval (CI) level.ResultsExcellent quality of sensory blocks and complete quality of motor blocks were achieved in all participants (100%). However, the mean time to onset of anesthesia (4.47 ± 0.69 vs. 3.38 ± 0.47, P < 0.001) and time to reach T10 level (60.73 ± 11.92 vs. 79.00 ± 19.21, P < 0.001) in the Group A, were significantly shorter than in the patients of Group B. The incidence of hypotension (P = 0.001), nausea/vomiting (P = 0.007) and bradycardia (P = 0.012) as well as administration of ephedrine and atropine were significantly higher in Group B compared to Group A.ConclusionSpinal anesthesia can be safely repeated with a 10 mg of hyperbaric bupivacaine 0.5% in a caesarean section after the initial spinal failure.Clinical trial registration[https://en.irct.ir/trial/40714], identifier [IRCT20120915010841N20].https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/fullmotor blockcesarean sectionbupivacainefailed spinalspinal anesthesiasensory block
spellingShingle Nahid Manouchehrian
Farshid Rahimi-Bashar
Azar Pirdehghan
Fatemeh Shahmoradi
Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
Frontiers in Medicine
motor block
cesarean section
bupivacaine
failed spinal
spinal anesthesia
sensory block
title Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
title_full Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
title_fullStr Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
title_full_unstemmed Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
title_short Comparison between 10 and 12 mg doses of intrathecal hyperbaric (0.5%) bupivacaine on sensory block level after first spinal failure in cesarean section: A double-blind, randomized clinical trial
title_sort comparison between 10 and 12 mg doses of intrathecal hyperbaric 0 5 bupivacaine on sensory block level after first spinal failure in cesarean section a double blind randomized clinical trial
topic motor block
cesarean section
bupivacaine
failed spinal
spinal anesthesia
sensory block
url https://www.frontiersin.org/articles/10.3389/fmed.2022.937963/full
work_keys_str_mv AT nahidmanouchehrian comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial
AT farshidrahimibashar comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial
AT azarpirdehghan comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial
AT fatemehshahmoradi comparisonbetween10and12mgdosesofintrathecalhyperbaric05bupivacaineonsensoryblocklevelafterfirstspinalfailureincesareansectionadoubleblindrandomizedclinicaltrial